106
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Guiding Significance of the Number of Positive Sentinel Lymph Nodes in Frozen Section for Intraoperative Axillary Dissection in Early Breast Cancer

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon &
Pages 4803-4810 | Published online: 17 Jun 2021

References

  • Krag DN , Anderson SJ , Julian TB , et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised Phase 3 trial. Lancet Oncol . 2010;11:927–933. doi:10.1016/S1470-2045(10)70207-2 20863759
  • Fleissig A , Fallowfield LJ , Langridge CI , et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat . 2006;95(3):279–293. doi:10.1007/s10549-005-9025-7 16163445
  • Veronesi U , Viale G , Paganelli G , et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg . 2010;251(4):595–600. doi:10.1097/SLA.0b013e3181c0e92a 20195151
  • Zavagno G , De Salvo GL , Scalco G , et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg . 2008;247(2):207–213. doi:10.1097/SLA.0b013e31812e6a73 18216523
  • Okuno J , Miyake T , Sota Y , et al. Development of prediction model including MicroRNA expression for sentinel lymph node metastasis in ER-positive and HER2-negative breast cancer. Ann Surg Oncol . 2020;28(10):310–319. doi:10.1245/s10434-020-08735-9 32583195
  • Zhang X , Yang Z , Cui W , et al. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer. Eur Radiol . 2021:1–16. doi:10.1007/s00330-020-07674-z 32767103
  • Lyman GH , Temin S , Edge SB , et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol . 2014;32(13):1365–1383. doi:10.1200/JCO.2013.54.1177 24663048
  • Wong J , Yong WS , Thike AA , et al. False negative rate for intraoperative sentinel lymph node frozen section in patients with breast cancer: a retrospective analysis of patients in a single Asian institution. J Clin Pathol . 2015;68(7):536–540. doi:10.1136/jclinpath-2014-202799 25855801
  • Akay CL , Albarracin C , Torstenson T , et al. Factors impacting the accuracy of intraoperative evaluation of sentinel lymph nodes in breast cancer. Breast J . 2018;24:28–34. doi:10.1111/tbj.12829 28608612
  • Giuliano AE , Hunt KK , Ballman KV , et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA . 2011;305(6):569–575. doi:10.1001/jama.2011.90 21304082
  • Galimberti V , Cole BF , Zurrida S , et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol . 2013;14:297–305. doi:10.1016/S1470-2045(13)70035-4 23491275
  • Straver ME , Meijnen P , van Tienhoven G , et al. Sentinel node identification rate and nodal involvement in the EORTC 10981–22023 AMAROS trial. Ann Surg Oncol . 2010;17:1854–1861. doi:10.1245/s10434-010-0945-z 20300966
  • Curigliano G , Burstein HJ , Winer EP , et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol . 2017;28:1700–1712. doi:10.1093/annonc/mdx308 28838210
  • Veronesi U , Paganelli G , Viale G , et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst . 1999;91:368–373. doi:10.1093/jnci/91.4.368 10050871
  • Weiser MR , Montgomery LL , Susnik B , et al. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol . 2000;7(9):651–655. doi:10.1007/s10434-000-0651-3 11034241
  • Rahusen FD , Pijpers R , Van Diest PJ , et al. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery . 2000;128(1):6–12. doi:10.1067/msy.2000.107229 10876178
  • Canavese G , Gipponi M , Catturich A , et al. Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery. Semin Surg Oncol . 1998;15(4):272–277. doi:10.1002/(SICI)1098-2388(199812)15:4<272::AID-SSU17>3.0.CO;2-I 9829386
  • Edge SB, Byrd DR, Compton CC, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
  • Hammond ME , Hayes DF , Wolff AC , et al. American society of clinical oncology/college of American pathologists Guideline Recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract . 2010;6(4):195–197. doi:10.1200/JOP.777003 21037871
  • Wolff AC , Hammond ME , Hicks DG , et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline update. Arch Pathol Lab Med . 2014;138(2):241–256. doi:10.5858/arpa.2013-0953-SA 24099077
  • Elston CW , Ellis IO . Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology . 1991;19(5):403–410. doi:10.1111/j.1365-2559.1991.tb00229.x 1757079
  • Dowsett M , Nielsen TO , A’Hern R , et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst . 2011;103(22):1656–1664. doi:10.1093/jnci/djr393 21960707
  • Fanizzi A , Pomarico D , Paradiso A , et al. Predicting of sentinel lymph node status in breast cancer patients with clinically negative nodes: a Validation Study. Cancers . 2021;13(2):352. doi:10.3390/cancers13020352 33477893
  • Chung A , Yu J , Stempel M , et al. Is the “10% rule” equally valid for all subsets of sentinel-node-positive breast cancer patients? Ann Surg Oncol . 2008;15(10):2728–2733. doi:10.1245/s10434-008-0050-8 18688679
  • Wong SL , Edwards MJ , Chao C , et al. Sentinellymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg . 2001;192:684–689. doi:10.1016/S1072-7515(01)00858-4 11400961
  • Nadia H , Altekruse SF , Li CI , et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst . 2014;106(5):2504–2511. doi:10.1093/jnci/dju055
  • Liu LC , Lang JE , Lu Y , et al. Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer . 2011;117:250–258. doi:10.1002/cncr.25606 20818649
  • Wada N , Imoto S , Hasebe T , et al. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol . 2004;34:113–117. doi:10.1093/jjco/hyh023 15078905
  • Jensen AJ , Naik AM , Pommier RF , et al. Factors influencing accuracy of axillary sentinel lymph node frozen section for breast cancer. Am J Surg . 2010;199(5):629–635. doi:10.1016/j.amjsurg.2010.01.017 20466107
  • Bishop JA , Sun J , Ajkay N , Sanders MAG . Decline in frozen section diagnosis for axillary sentinel lymph nodes as a result of the American College of Surgeons Oncology Ggroup Z0011 trial. Arch Pathol Lab Med . 2016;140:830–835. doi:10.5858/arpa.2015-0296-OA 26716950
  • Yoon KH , Park S , Kim HS , et al. Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients? Ann Surg Treat Res . 2019;97:49–57. doi:10.4174/astr.2019.97.2.49 31388507
  • Weaver DL , Ashikaga T , Krag DN , et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med . 2011;364(5):412–421. doi:10.1056/NEJMoa1008108 21247310